| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.5 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |